Amsterdam, Netherlands
Write a Review
Our Products
Leading Manufacturer, Supplier & Retailer of Blue Mounjaro Tirzepatide Injection and Mounjaro 15mg Injection.
Tirzepatide is a novel first-in-class drug that is used to treat type 2 diabetes and licensed in the US. The tirzepatide drug is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. GIP and GLP-1 are hormones called incretins that are released by the intestines.
Both GIP and GLP-1 increase the production of insulin, with GLP-1 promoting a feeling of fullness and delaying stomach emptying and controlling appetite.
GIP has an effect to reduce fat accumulation, increases bone formation, increases glucagon production, and reduces acid secretion in the stomach.
The combination of GIP and GLP-1 agonists makes tirzepatide a unqiue and very effective medication.
The medication is administered as a once weekly subcutaneous injection into the midriff, upper arm or thigh.
The medication is titrated on a 5mg, 10mg and 15mg dosage dependant on blood sugar and the propensity for side effects from a patient.
Additional Information:
Payment Terms : T/T, Western Union,
Packaging Details : Packs
Delivery Time : 4 days
Mounjaro is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes.
Brand Name:MOUNJARO
Generic Name:tirzepatide
Strength:Injection: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen
Manufacturer:Eli Lilly and Company
Approved By:EMA, USFDA
Additional Information:
Payment Terms : T/T, Western Union
Packaging Details : packs and boxes
Delivery Time : 4 days
Gerarld (Jona Biotechnology)Amsterdam - 413, Netherlands
https://www.jonabiotechnology.in
Share us via
